Cushing’s Syndrome - Opportunity Assessment and Forecast to 2030
Summary Cushing’s Syndrome is a disorder caused by the body’s exposure to an excess of the hormone cortisol.Cortisol affects all tissues and organs in the body, and collectively these effects are known as CS.
This disorder can be caused by exogenous sources, primarily the iatrogenic administration of glucocorticoids. Endogenous CS can result from a tumor of the adrenal glands where it produces excess cortisol, elsewhere in the body, ACTH-independent CS, or an ACTH-secreting tumor of the pituitary gland, which stimulates the adrenal glands to produce excess amounts of cortisol (CD).
This report covers 2mm (US and Germany) and provides an Excel-based forecast model for the Cushing’s Syndrome market through 2030.
Key Highlights - Forecasts include three countries - Forecasts cover three time points: base year, 5-year, and 10-year
Scope - "Cushing’s Syndrome - Opportunity Assessment and Forecast to 2030" combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.
Reasons to Buy - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global CS market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global CS market in the future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Our reports have been used by over 10K customers, including:
The global peptide synthesis market is projected to reach USD 730 million by 2026 USD 515 million in 2021, at a CAGR of 7.2% during the forecast period. Growth in this market is driven by the increasing use of peptides in pharmaceutical drugs, increase in research activities and availability of funding for R&D, and the development of advanced...
The global hydrazine market reached a value of around US$ 416 Million in 2020. Looking forward, the analyst expects the market to exhibit stable growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic....
411 pages •
By IQ4I Research & Consultancy Pvt. Ltd
• Nov 2021
Toxicology is the study of adverse effects that occur in living organisms and its environment due to chemicals, physical or biological substances at ambient exposure levels. Toxicology testing regulations are already in place for most of the developed countries across industries such as chemicals, pesticides, consumer...
“Cyclin-Dependent Kinase 9 (CDK9) Inhibitor - Pipeline Insight, 2022” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Cyclin-Dependent Kinase 9 (CDK9) Inhibitor pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment...
Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) - Drugs in Development, 2021 Summary Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) - Bcl-2-like protein 1 is a protein encoded by the BCL2L1 gene. It belongs to BCL-2 family. It is a potent inhibitor of cell death....
The global human microbiome market exhibited strong growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of around 18% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the...
The global albumin market exhibited moderate growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of around 5% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic...
Research And Development
Digestive System Disorder
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.